Fig. 3From: Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 statusHER2 subgroups had differentially mutated genes (A–C) and molecular signaling pathways (D–F)Back to article page